UPDATE : Friday, June 5, 2020
Regulator OKs Pfizer's Vizimpro as 1st-line treatment of mutated lung cancer
Pfizer Korea said Thursday that the Ministry of Food and Drug Safety has ap...
by Shim Hyun-tai  |  2020-02-20 18:47
Daewoong’s Nabota gets item license in Brazil
Daewoong Pharmaceutical said Thursday that its botulinum product, Nabota, h...
by Shim Hyun-tai  |  2020-02-20 16:11
Drugmakers rush to roll out famotidine to replace ranitidine
Local pharmaceutical companies are quickly releasing medicines containing f...
by Jeong Sae-im  |  2020-02-18 15:07
Medytox's Meditoxin gets new indication for cervical dystonia
Medytox said Tuesday that its botulinum toxin preparation, Meditoxin, has r...
by Shim Hyun-tai  |  2020-02-18 15:06
JW wins US patent for world’s 1st multi-biomarker diagnostic kit
JW Holdings said Monday that it has obtained a patent in the United States ...
by Shim Hyun-tai  |  2020-02-17 17:54
Genexine’s US affiliate gets FDA nod for immune booster trial
NeoImmuneTech, Genexine's affiliate, received approval from the U.S. Fo...
by Shim Hyun-tai  |  2020-02-17 12:46
Helixmith gets mixed results from p3-1 trials of gene therapy
Helixmith said Friday that the clinical trial phase 3-1 result of Engensis ...
by Shim Hyun-tai  |  2020-02-14 18:12
Eisai to pull out antiobesity drug Belviq from US market
Eisai Pharmaceutical, a Japan-based multinational drug firm, has decided to...
by Lee Han-soo  |  2020-02-14 16:38
Daewoong’s sales reached ₩1 trillion milestone in 2019
Daewoong Pharmaceutical said that its sales exceeded 1 trillion won ($845.8...
by Lee Han-soo  |  2020-02-14 14:33
JW Pharmaceutical turns to loss on reduced sales of nutrients
JW Pharmaceutical said it reported operating loss in 2019, turning from an ...
by Jeong Sae-im  |  2020-02-14 12:03
Mediforum turned around to net profit in 2019
Mediforum, a pharmaceutical specialized in developing degenerative brain di...
by Shim Hyun-tai  |  2020-02-13 17:43
Bukwang's dyskinesia treatment gets FDA nod for p 2 trials
The U.S. Food and Drug Administration has recently approved the phase 2 cli...
by Shim Hyun-tai  |  2020-02-13 14:22
Dong-A ST posts robust profit in 2019
Dong-A ST said Thursday that it recorded sales of 612.2 billion won ($518.2...
by Lee Han-soo  |  2020-02-13 14:20
ISU’s US partner releases clinical trial results of new hemophilia treatment
ISU Abxis, an orphan drug developer, said Wednesday that its U.S. partner, ...
by Shim Hyun-tai  |  2020-02-13 11:18
SK Plasma to enter ME market with self-developed tech
SK Plasma has signed a memorandum of understanding with Arab Company for Dr...
by Shim Hyun-tai  |  2020-02-12 17:16
Daewoong teams up with ADM Korea to develop new drugs
Daewoong Pharmaceutical said Wednesday that the company has signed a memora...
by Shim Hyun-tai  |  2020-02-12 15:58
Bridge Biotherapeutics, Konkuk University to develop back-eye diseases treatment
Bridge Biotherapeutics has agreed with Konkuk University to introduce techn...
by Lee Han-soo  |  2020-02-12 14:49
GC’s sales rose but profits fell in 2019
GC said Wednesday it recorded sales of 1.36 trillion won ($1.1 billion) las...
by Lee Han-soo  |  2020-02-12 11:40
Medipost’s sales edge up, losses widen last year
Medipost said Wednesday that the company’s operating and net losses magnifi...
by Lee Han-soo  |  2020-02-12 11:40
MSD Korea workers unhappy with spinoff plan
After MSD announced its “strategy” to separate some medicines under a new c...
by Kim Yun-mi  |  2020-02-11 14:57
Back to Top